<DOC>
	<DOCNO>NCT02746263</DOCNO>
	<brief_summary>The purpose study compare intravenous ( IV ) oral acetaminophen treatment acute moderate severe pain combination standardize patient-controlled analgesia ( PCA ) adult subject follow total knee replacement .</brief_summary>
	<brief_title>Multicenter Study Compare Intravenous Oral Acetaminophen Treatment Acute Moderate Severe Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>1 . Subject must adequately inform understand nature risk study must able provide signature date inform consent form . 2 . Subject must male female , 50 90 year age ( inclusive ) Screening . 3 . Subject must weight range 50 120 kg . 4 . Subject must American Society Anesthesiologists risk class I , II , III . 5 . Subject must successfully complete unilateral uncomplicated total knee replacement surgery , able take oral medication , report moderate severe acute pain determine pain score ≥ 5 11point Numeric Pain Rating Scale ( NPRS ) scale period 3 6 hour postsurgery . 6 . Female subject childbearing potential must negative serum pregnancy test Screening dayofsurgery . 7 . Subjects must able communicate effectively study personnel . 8 . Subject must able willing follow protocol requirement , include operate PCA device , study restriction . 1 . Subject vulnerable population , define Code Federal Regulations Title 45 , Part 46 , 1 . Section 46.111 ( b ) , include limited employee ( temporary , parttime , full time , etc . ) family member research staff conduct study , sponsor , clinical research organization , Institutional Review Board . 2 . Subject oxygen saturation le 95 % awake room air . 3 . Subject positive test result human immunodeficiency virus , hepatitis B ( surface antigen ) , hepatitis C virus antibody Screening . 4 . Subject use average 30 mg oral morphine equivalent great , 1 2 week prior day surgery . Subjects , investigator 's opinion develop opioid tolerance exclude . 5 . Subject history drug allergy , hypersensitivity , intolerance acetaminophen morphine excipients IV oral formulation use . 6 . Subject intra postoperative complication , view investigator , make subject unsuitable participation study . 7 . Subject receive neuraxial ( spinal epidural ) opioid inject perioperatively . 8 . Subject receive local anesthetic , regional , wound injection continuous infusion route . 9 . Subject impaired liver function ( eg , aspartate aminotransferase , alanine aminotransferase , bilirubin great equal 3.0 time upper limit normal ) , active hepatic disease , evidence clinically significant liver disease , condition ( eg , alcoholism , cirrhosis , hepatitis ) suggest potential increase susceptibility hepatic toxicity study drug exposure . 10 . Subject renal dysfunction risk renal failure due volume depletion . 11 . Subject donate significant loss whole blood ( 480 mL ) within 30 day , plasma within 14 day prior dose . 12 . Subject major surgery within 3 month prior dayofsurgery . 13 . Subject history acute illness within 14 day prior dayofsurgery . 14 . Subject participate another clinical study within 30 day prior dayofsurgery plan participate another clinical study concurrently enrol study . 15 . Subject history condition might specifically contraindicate require caution use administration drug study . 16 . Subject medical , psychiatric and/or social reason exclusion determine investigator . 17 . Subject positive test result drug abuse ( amphetamine , barbiturate , benzodiazepine , cannabinoids [ include medical use marijuana ] , cocaine , methamphetamine , methadone , methylenedioxymethamphetamine ) Screening . Subjects positive test result prescribe drug may include study discretion investigator . Subjects positive test result cannabinoids prescription medical marijuana exclude study , subject prescription dronabinol ( ∆9tetrahydrocannabinol ) may include discretion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Elective total knee arthroplasty</keyword>
</DOC>